Microfluidic Cassette for Point-of-Care Viral Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting viral infections, such as COVID-19, Ebola, and Yellow Fever, are inefficient and lack portable, user-friendly diagnostic devices that can be used by minimally trained healthcare providers, especially in remote areas, and there is a need for rapid and accurate detection of these viruses and serological immunity.
Innovation Solution
A system and method for detecting viruses using a disposable microfluidic assay cassette that separates plasma from blood, reconstitutes test reagents, and performs serological immune response analysis, allowing for point-of-care detection of viral antibodies or antigens within 15 minutes using a small sample volume, without requiring electrical means for sample movement.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional laboratory-based detection methods are used, then detection accuracy is maintained, but device complexity and requirement for trained personnel increase
Solution Approach 1:
The system divides the diagnostic process into discrete modular components: sample collection device, microfluidic processing module with integrated plasma separation, reagent reservoirs, and detection module. Each module performs a specific function and can be independently manufactured and validated, reducing overall system complexity while maintaining diagnostic accuracy through standardized interfaces and protocols
Solution Approach 2:
The microfluidic system performs automated plasma separation from whole blood through integrated filtration membranes and capillary-driven fluid transport, eliminating the need for manual centrifugation or trained phlebotomy techniques. The system self-regulates fluid flow rates and timing through passive microfluidic design, enabling untrained personnel to obtain accurate results
2Measurement precision
If conventional laboratory methods are used, then comprehensive analysis is achieved, but loss of time in sample transport and processing increases
Solution Approach 1:
The system combines multiple laboratory functions into a single portable device: blood sampling, plasma separation via microfluidic filtration, reagent mixing, incubation, and optical detection all occur within one integrated platform. This consolidation eliminates sample transport between laboratories and enables complete diagnostic workflow in approximately 15 minutes at the point of care
Solution Approach 2:
Dried blood spots are collected and stabilized at the point of care, preserving sample integrity without requiring immediate processing or cold chain storage. The microfluidic system then performs preliminary plasma separation and antigen-antibody binding reactions before final detection, enabling rapid turnaround without compromising analytical accuracy
3Ease of operation
If portable detection devices are developed, then ease of operation in remote areas is improved, but measurement precision may deteriorate
Solution Approach 1:
The system replaces complex mechanical laboratory equipment (centrifuges, automated analyzers, temperature-controlled incubators) with passive microfluidic structures that use capillary forces, surface tension, and pressure gradients to drive fluid flow and reactions. This substitution maintains analytical precision while enabling operation in remote settings without electricity or trained technicians
Solution Approach 2:
The system optimizes reaction conditions by controlling key parameters within narrow ranges: microfluidic channel dimensions regulate flow rates and mixing efficiency, membrane pore sizes control plasma filtration, and pre-loaded reagent concentrations ensure optimal binding conditions. These parameter optimizations maintain laboratory-grade detection accuracy in a simplified portable format
4Ease of operation
If small sample volumes are used, then patient comfort and sample collection ease are improved, but detection sensitivity may worsen
Solution Approach 1:
The system uses dried blood spot sampling, where a small volume of blood (50-100 µL) is applied to filter paper and air-dried, creating a stable copy of the original sample that can be stored and transported without degradation. This copying approach preserves analyte integrity while minimizing patient discomfort and collection complexity
Solution Approach 2:
The microfluidic system incorporates porous filtration membranes with controlled pore sizes that enable efficient plasma separation from small blood volumes. The high surface area-to-volume ratio of the porous structure maximizes filtration efficiency, allowing adequate plasma recovery from minimal sample inputs while maintaining detection sensitivity through concentrated analyte recovery
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid, accurate, and portable detection of viral infections and immunity at the point of care, using a small sample volume, reducing the need for laboratory equipment and trained personnel, and facilitating disease surveillance in resource-limited settings.
Implementation Method 1
separates plasma from blood
Implementation Method 2
without requiring electrical means for sample movement
Implementation Method 3
performs serological immune response analysis, allowing for point-of-care detection of viral antibodies or antigens
Data Source
AI summary
The present invention provides a system and methods for the detection of peptides from and antibodies against coronaviruses, filoviruses, flaviviruses, or combination thereof, in a sample. A method for detecting the presence of a coronavirus in a sample may comprise: collecting a small sample of a biological fluid from the test subject, adding sample to a viral test cassette, initiating sample processing by the assay cassette to incubate the diluted sample and developing reagents with an antibody microarray contained within the cassette, and results of the test are read by visual examination and process the results to determine if the subject is infected by a coronavirus.